← Leaderboards
William T. Cefalu
University Of Vermont &St Agric College
$17,216,940
Attributed
$17,216,940
Total exposure
26
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.5M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$34,786,657 · 27
By mechanism
P50$29,473,799 · 15
R01$2,498,726 · 3
U54$1,770,695 · 1
R21$579,364 · 1
M01$364,073 · 6
R55$100,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Botanicals”
- Ikhlas Ahmad Khan · University Of Mississippi$39,794,183
- Larry A Walker · University Of Mississippi$13,915,445
- Edward G Shaw · Wake Forest University Health Sciences$11,198,531
- Brian Burback · Battelle Centers/Pub Hlth Res & Evaluatn$9,512,458
- David G Kingston · Virginia Polytechnic Inst And St Univ$9,493,374
- Richard B Van Breemen · Oregon State University$8,612,646
Research focus
BotanicalsMetabolic SyndromeObesityResearch PersonnelInsulin SensitivityInsulinFundingDietary SupplementsInsulin ResistanceArtemisiaInsulin ReceptorClinical ResearchMolecularBaseIn VivoMetabolicProteomicsAttenuatedBiologyEvaluationReceptor SignalingFunctional DisorderInstructionMetabolomics
Grant awards (78)
Administrative Core$471,255
U54 · FY2020 · GM · contact PI
Administrative Core$466,316
U54 · FY2019 · GM · contact PI
Cefalu: Project 1; Botanicals and Metabolic Flexibility (Cefalu)$366,263
P50 · FY2019 · AT · contact PI
Administrative Core$469,487
U54 · FY2018 · GM · contact PI
Cefalu: Project 1; Botanicals and Metabolic Flexibility (Cefalu)$366,263
P50 · FY2018 · AT · contact PI
Cefalu: Project 1; Botanicals and Metabolic Flexibility (Cefalu)$366,263
P50 · FY2017 · AT · contact PI
Administrative Core$363,637
U54 · FY2017 · GM · contact PI
Cefalu: Overall; Botanicals and Metabolic Resiliency (Cefalu)$1,840,664
P50 · FY2015 · AT · contact PI
Cefalu: Administrative Core (Cefalu)$360,692
P50 · FY2015 · AT · contact PI
Cefalu: Project 1; Botanicals and Metabolic Flexibility (Cefalu)$285,641
P50 · FY2015 · AT · contact PI
Botanicals and Metabolic Syndrome$1,622,369
P50 · FY2014 · AT · contact PI
Pregnane and Glycosides and Obesity/llya Raskin$536,732
P50 · FY2014 · AT · contact PI
Botanical Research Core/David M. Ribnicky$354,813
P50 · FY2014 · AT · contact PI
Integrative Biology Core/Thomas W. Gettys$322,133
P50 · FY2014 · AT · contact PI
Adipocytes and Botanicals/Jacequeline M. Stephens$222,813
P50 · FY2014 · AT · contact PI
Artemisia SP and Insulin Action/William T. Cefalu$185,878
P50 · FY2014 · AT · contact PI
Botanicals and Metabolic Syndrome$1,588,979
P50 · FY2013 · AT · contact PI
Pregnane and Glycosides and Obesity/llya Raskin$525,784
P50 · FY2013 · AT · contact PI
Botanical Research Core/David M. Ribnicky$347,472
P50 · FY2013 · AT · contact PI
Integrative Biology Core/Thomas W. Gettys$315,462
P50 · FY2013 · AT · contact PI
Adipocytes and Botanicals/Jacequeline M. Stephens$218,245
P50 · FY2013 · AT · contact PI
Artemisia SP and Insulin Action/William T. Cefalu$182,016
P50 · FY2013 · AT · contact PI
Botanicals and Metabolic Syndrome$95,505
P50 · FY2013 · AT · contact PI
Botanicals and Metabolic Syndrome$47,293
P50 · FY2013 · AT · contact PI
Botanicals and Metabolic Syndrome$1,513,518
P50 · FY2012 · AT · contact PI
Pregnane and Glycosides and Obesity/llya Raskin$502,560
P50 · FY2012 · AT · contact PI
Botanical Research Core/David M. Ribnicky$330,237
P50 · FY2012 · AT · contact PI
Integrative Biology Core/Thomas W. Gettys$299,630
P50 · FY2012 · AT · contact PI
Adipocytes and Botanicals/Jacequeline M. Stephens$208,576
P50 · FY2012 · AT · contact PI
Artemisia SP and Insulin Action/William T. Cefalu$172,513
P50 · FY2012 · AT · contact PI
Botanicals and Metabolic Syndrome$1,461,528
P50 · FY2011 · AT · contact PI
Pregnane and Glycosides and Obesity/llya Raskin$562,131
P50 · FY2011 · AT · contact PI
Botanical Research Core/David M. Ribnicky$370,624
P50 · FY2011 · AT · contact PI
Integrative Biology Core/Thomas W. Gettys$336,251
P50 · FY2011 · AT · contact PI
Adipocytes and Botanicals/Jacequeline M. Stephens$235,933
P50 · FY2011 · AT · contact PI
Artemisia SP and Insulin Action/William T. Cefalu$193,555
P50 · FY2011 · AT · contact PI
Botanicals and Metabolic Syndrome$160,752
P50 · FY2011 · AT · contact PI
Botanicals and Metabolic Syndrome$152,727
P50 · FY2011 · AT · contact PI
Botanicals and Metabolic Syndrome$1,508,302
P50 · FY2010 · AT · contact PI
Artemisia SP and Insulin Action/William T. Cefalu$527,600
P50 · FY2010 · AT · contact PI
Integrative Biology Core/Thomas W. Gettys$427,003
P50 · FY2010 · AT · contact PI
Botanical Research Core/David M. Ribnicky$335,202
P50 · FY2010 · AT · contact PI
Pregnane and Glycosides and Obesity/llya Raskin$272,194
P50 · FY2010 · AT · contact PI
Botanicals and Metabolic Syndrome$243,233
P50 · FY2010 · AT · contact PI
Adipocytes and Botanicals/Jacequeline M. Stephens$189,536
P50 · FY2010 · AT · contact PI
Botanicals and Metabolic Syndrome$1,456,499
P50 · FY2009 · AT · contact PI
PMI-5011 and Insulin Action$354,777
P50 · FY2009 · AT · contact PI
Botanicals and Metabolic Syndrome$1,427,369
P50 · FY2008 · AT · contact PI
PMI-5011 and Insulin Action$356,216
P50 · FY2008 · AT · contact PI
Botanicals and Metabolic Syndrome$1,456,501
P50 · FY2007 · AT · contact PI
PMI-5011 and Insulin Action$351,763
P50 · FY2007 · AT · contact PI
Administrative Core$171,026
P50 · FY2007 · AT · contact PI
Chromium, Cellular Energy Status and Whole Body Energy Balance$143,546
R21 · FY2007 · AT · contact PI
Botanicals and Metabolic Syndrome$1,494,741
P50 · FY2006 · AT · contact PI
Chromium and Insulin Action$426,315
R01 · FY2006 · DK · contact PI
PMI-5011 and Insulin Action$247,946
P50 · FY2006 · AT · contact PI
Chromium, Cellular Energy Status and Whole Body Energy Balance$215,318
R21 · FY2006 · AT · contact PI
Botanicals and Metabolic Syndrome$1,499,737
P50 · FY2005 · AT
Chromium and Insulin Action$423,858
R01 · FY2005 · DK
Administrative Core$283,919
P50 · FY2005 · AT
Chromium, Cellular Energy Status, Whole Body Energy Bala$220,500
R21 · FY2005 · AT
PMI-5011 and Insulin Action$218,420
P50 · FY2005 · AT
HRT TO AUGMENT LOSS OF VISCERAL FAT AND IMPROVE INSULIN SENSITIVITY$21,253
M01 · FY2005 · RR
Chromium and Insulin Action$415,195
R01 · FY2004 · DK
HRT to Augment Loss of Visceral Fat and Improve Insulin Sensitivity$173,132
M01 · FY2004 · RR
Chromium vs Factors Regulating Insulin Sensitivity in Type 2 Diabetes$79,567
M01 · FY2004 · RR
Effect of Chromium Picolinate on Glucose Control in Type II Diabetic Patients$11,787
M01 · FY2004 · RR
Changes in Body Comp. &Insulin Sens. on Cardiovascular Risk in Type 2 Diabetes$6,631
M01 · FY2004 · RR
Chromium and Insulin Action$419,347
R01 · FY2003 · DK
HORMONE REPLACEMENT FOR PREVENTION OF VISCERAL OBESITY$180,306
R01 · FY2002 · AG
EFFECT OF CHROMIUM PICOLINATE ON GLUCOSE CONTROL IN TYPE 2 DIABETIC PATIENTS$0
M01 · FY2002 · RR
CALORIC RESTRICTION, AGING, AND INSULIN ACTION$221,292
R01 · FY2001 · AG
HORMONE REPLACEMENT FOR PREVENTION OF VISCERAL OBESITY$180,578
R01 · FY2001 · AG
Chromium and Insulin Action$100,000
R55 · FY2001 · DK
CALORIC RESTRICTION, AGING, AND INSULIN ACTION$231,835
R01 · FY2000 · AG
COMPARISON OF GLUCOTROL AND METFORMIN ALONE AND COMBINED IN PATIENTS WITH NIDDM$38,800
M01 · FY2000 · RR
EFFECT OF CHROMIUM PICOLINATE ON GLUCOSE CONTROL IN TYPE 2 DIABETIC PATIENTS$32,903
M01 · FY2000 · RR
EFFECT OF CHROMIUM PICOLINATE ON GLUCOSE CONTROL IN TYPE 2 DIABETIC PATIENTS$0
M01 · FY2000 · RR